His research exploring the value and feasibility of supervised injection facilities was fundamental to establishing the evidence base for these services in Canada. In Toronto, his work was used by public health officials, community groups, and elected officials to support applications to the Federal Government that resulted in the introduction of supervised injection facilities in Toronto.
Dr. Bayoumi is a MAP scientist and a St. Michael’s Hospital physician. He is the inaugural Scientific Director of Converge3, a policy research centre based in the University of Toronto’s Institute of Health Policy, Management and Evaluation that focuses on integrating health, economic and equity evidence to inform policy. He is also past president of the Society for Medical Decision Making and a member of the Canadian Drug Expert Committee. He is a scientist with the Li Ka Shing Knowledge Institute, adjunct scientist at ICES and a professor in the University of Toronto’s Department of Medicine and Institute of Health Policy, Management and Evaluation.